Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab‐naïve relapsed multiple myeloma.
Saved in:
| Title: | Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab‐naïve relapsed multiple myeloma. |
|---|---|
| Authors: | Dima, Danai1,2 (AUTHOR), Mansour, Razan2,3 (AUTHOR), Davis, James A.2,4 (AUTHOR), Minchak, Megan2,5 (AUTHOR), Goel, Utkarsh1 (AUTHOR), Atallah, Rawan2,3 (AUTHOR), Logan, Emerson2,6 (AUTHOR), Tabak, Carine2,6 (AUTHOR), Rashid, Aliya2,3 (AUTHOR), Ahmed, Nausheen2,3 (AUTHOR), Abdallah, Al‐Ola2,3 (AUTHOR), Hashmi, Hamza2,4,7 (AUTHOR) hamzahashmi87@hotmail.com |
| Source: | European Journal of Haematology. Jun2024, Vol. 112 Issue 6, p975-983. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 09024441 |
|---|---|
| DOI: | 10.1111/ejh.14193 |
